SlideShare uma empresa Scribd logo
1 de 38
Drug Development Research in
Preclinical Imaging Centre (PRIME)



        Prof. dr. Otto C. Boerman
RTM: Radboud Translational Medicine
                   from molecule to man




Discovery       Screening   preclinical testing               Clinical trials




                                           Radboud University Nijmegen Medical Centre, The Netherlands
RTM: Radboud Translational Medicine
                   from molecule to man




Discovery       Screening   preclinical testing               Clinical trials




                                           Radboud University Nijmegen Medical Centre, The Netherlands
PRIME: Preclinical Imaging Centre




                                                 microSPECT




                            Radboud University Nijmegen Medical Centre, The Netherlands
From human imaging to small animal imaging
From human imaging to small animal imaging
 Mouse                 Human

 Uptake of 123I-IBF
  by D2 receptors




 Neurology                      Dopamine w/ 99mTc-TRODAT

   99m
       Tc-MIBI




Cardiovascular                       Stress 99mTc-MIBI

 [99mTc] Minigastrin




   Oncology                           Renal Cell Carcinoma
 *functional imaging
Radboud University Nijmegen Medical Centre, The Netherlands
Radboud University Nijmegen Medical Centre, The Netherlands
Radboud University Nijmegen Medical Centre, The Netherlands
Radboud University Nijmegen Medical Centre, The Netherlands
Radboud University Nijmegen Medical Centre, The Netherlands
PRIME
Preclinical Imaging Centre




                        microSPECT




    PET imaging in PRIME
                             Radboud University Nijmegen Medical Centre, The Netherlands
Annihilation




               Radboud University Nijmegen Medical Centre, The Netherlands
FDG-PET: imaging cancer




Normal FDG-PET    Metastasized Melanoma
FDG-PET: functional imaging
        Monitor response to treatment


                                                                         Pre treatment




                                                                         4 weeks after
                                                                         start of treatment




                                                                         24 weeks after
                                                                         start of treatment




Pre treatment




                    Dept. Nuclear Medicine, Radboud University Nijmegen Medical Centre
FDG-PET: functional imaging
        Monitor response to treatment


                                                                               Pre treatment




                                                                               4 weeks after
                                                                               start of treatment




                                                                               24 weeks after
                                                                               start of treatment




Pre treatment   1 week after start of
                imatinib treatment



                          Dept. Nuclear Medicine, Radboud University Nijmegen Medical Centre
FDG-PET: functional imaging
        Monitor response to treatment


                                                                               Pre treatment




                                                                               4 weeks after
                                                                               start of treatment




                                                                               24 weeks after
                                                                               start of treatment




Pre treatment   1 week after start of
                imatinib treatment



                          Dept. Nuclear Medicine, Radboud University Nijmegen Medical Centre
microPET/CT scanner




                 Radboud University Nijmegen Medical Centre, The Netherlands
Monitor the therapeutic effect
            of a new anti-cancer drug




- 1 day


                                  Radboud University Nijmegen Medical Center, The Netherlands
Monitor the therapeutic effect
            of a new anti-cancer drug




- 1 day          1 day


                                  Radboud University Nijmegen Medical Center, The Netherlands
Monitor the therapeutic effect
            of a new anti-cancer drug




- 1 day          1 day        3 days


                                       Radboud University Nijmegen Medical Center, The Netherlands
Monitor the therapeutic effect
            of a new anti-cancer drug




- 1 day          1 day        3 days                            7 days


                                       Radboud University Nijmegen Medical Center, The Netherlands
PRIME
Preclinical Imaging Centre




                        microSPECT




   SPECT imaging in PRIME
                             Radboud University Nijmegen Medical Centre, The Netherlands
Small animal SPECT imaging




                  Radboud University Nijmegen Medical Centre, The Netherlands
Radboud University Nijmegen Medical Centre, The Netherlands
                                                        25
microSPECT imaging




               Radboud University Nijmegen Medical Centre, The Netherlands
Imaging transplated islets of Langerhans

Diabetes type 1: autoimmune destruction of insulin producing beta cells

Islet transplantation is a promising treatment for patients with type1 diabetes

AIM: Non-invasive in vivo determination of beta cell mass after islet transplantation.


                                                 In-111-DTPA-
                                                 Exendin
                           islets




                                                               Radboud University Nijmegen Medical Centre, The Netherlands
Imaging transplated islets of Langerhans




                          Radboud University Nijmegen Medical Centre, The Netherlands
Imaging transplated islets of Langerhans


2D


                 3W


In-111-Exendin



                           6W



                                      8W


                                                                    11W




                                           Radboud University Nijmegen Medical Centre, The Netherlands
PRIME
      Preclinical Imaging Centre




                               microSPECT




Intravital fluorescence imaging in PRIME
                                   Radboud University Nijmegen Medical Centre, The Netherlands
Multi-photon fluorescence microscopy




                         Radboud University Nijmegen Medical Centre, The Netherlands
Multi-photon fluorescence microscopy

Monitoring of tumor development using the dorsal skinfold chamber model




                                                Radboud University Nijmegen Medical Centre, The Netherlands
Multi-photon fluorescence microscopy

                                                  Tumor cells

                                                  Extracellular
                                                  matrix, collagen,
                                                  muscle fibers

                                                  Fat cells, nerves

                                                  Blood vessels,
                                                  immune cells




                         Radboud University Nijmegen Medical Centre, The Netherlands
Multi-photon fluorescence microscopy


                                               Tumor cells

                                               Extracellular matrix,
                                               collagen, muscle fibers

                                               Fat cells, nerves

                                               Blood vessels, immune
                                               cells




                          Radboud University Nijmegen Medical Centre, The Netherlands
Immunofluorescence Guided Surgery




                       Radboud University Nijmegen Medical Center, The Netherlands
Immunofluorescence Guided Surgery




                       Radboud University Nijmegen Medical Center, The Netherlands
Multi-modality Imaging




Fluorescence imaging




                          MRI




                                     PET

                                                                  Multiphoton imaging


                                       Radboud University Nijmegen Medical Centre, The Netherlands
Drug development Research

Hoffmann La Roche
Novartis
Sanofi
Fuji Biotechnology


Future Chemistry
Immunomedics Inc.
Synaffix
Wilex
Milabs


                       Radboud University Nijmegen Medical Centre, The Netherlands

Mais conteúdo relacionado

Semelhante a Otto Boerman

What is Nuclear Medicine and PET?
What is Nuclear Medicine and PET?What is Nuclear Medicine and PET?
What is Nuclear Medicine and PET?todd_charge
 
Precision Oncology: Combining Orthotopic-PDX Models and MRI, Moving Research ...
Precision Oncology: Combining Orthotopic-PDX Models and MRI, Moving Research ...Precision Oncology: Combining Orthotopic-PDX Models and MRI, Moving Research ...
Precision Oncology: Combining Orthotopic-PDX Models and MRI, Moving Research ...Scintica Instrumentation
 
Sebastiani Gian Domenico Torino 13° Convegno Patologia Immune E Malattie Orfa...
Sebastiani Gian Domenico Torino 13° Convegno Patologia Immune E Malattie Orfa...Sebastiani Gian Domenico Torino 13° Convegno Patologia Immune E Malattie Orfa...
Sebastiani Gian Domenico Torino 13° Convegno Patologia Immune E Malattie Orfa...cmid
 
A New Frontier of Precision Medicine: Using PET for Image-Guided Neurointerve...
A New Frontier of Precision Medicine: Using PET for Image-Guided Neurointerve...A New Frontier of Precision Medicine: Using PET for Image-Guided Neurointerve...
A New Frontier of Precision Medicine: Using PET for Image-Guided Neurointerve...InsideScientific
 
Interventional Nuclear Medicine Treatment
Interventional Nuclear Medicine TreatmentInterventional Nuclear Medicine Treatment
Interventional Nuclear Medicine TreatmentSarvodayaHospital1
 
Approaches in clinical trial
Approaches in clinical trialApproaches in clinical trial
Approaches in clinical trialtabirsir
 
DESTINY – An Innovative Platform for Personalized Medicine from Doctors for D...
DESTINY – An Innovative Platform for Personalized Medicine from Doctors for D...DESTINY – An Innovative Platform for Personalized Medicine from Doctors for D...
DESTINY – An Innovative Platform for Personalized Medicine from Doctors for D...IFAH
 
Emerging Role of PRRT.pdf
Emerging Role of PRRT.pdfEmerging Role of PRRT.pdf
Emerging Role of PRRT.pdfMahaManap1
 
Medical Imaging Seminar Company Presentations
Medical Imaging Seminar Company PresentationsMedical Imaging Seminar Company Presentations
Medical Imaging Seminar Company PresentationsSpace IDEAS Hub
 
Certis preclinical slideshare 7.28.18
Certis preclinical slideshare 7.28.18Certis preclinical slideshare 7.28.18
Certis preclinical slideshare 7.28.18ArthurHolmes2
 
MDC Connects Series 2021 | A Guide to Complex Medicines: Physicochemical Char...
MDC Connects Series 2021 | A Guide to Complex Medicines: Physicochemical Char...MDC Connects Series 2021 | A Guide to Complex Medicines: Physicochemical Char...
MDC Connects Series 2021 | A Guide to Complex Medicines: Physicochemical Char...Medicines Discovery Catapult
 
Pet ct in pediatric malignancies
Pet ct in pediatric malignanciesPet ct in pediatric malignancies
Pet ct in pediatric malignancieslakshmipathy kadur
 
In Vivo Bioluminescent / Fluorescent Imaging
In Vivo Bioluminescent / Fluorescent ImagingIn Vivo Bioluminescent / Fluorescent Imaging
In Vivo Bioluminescent / Fluorescent Imagingachang07
 
Translational Applications of MiniPDX: An In Vivo Organoid Assay in New Drug R&D
Translational Applications of MiniPDX: An In Vivo Organoid Assay in New Drug R&DTranslational Applications of MiniPDX: An In Vivo Organoid Assay in New Drug R&D
Translational Applications of MiniPDX: An In Vivo Organoid Assay in New Drug R&DInsideScientific
 
Nanotechnology in drug delivery final
Nanotechnology in drug delivery finalNanotechnology in drug delivery final
Nanotechnology in drug delivery finalpooja roy
 
Advances in radiation oncology:Cancer care
Advances in radiation oncology:Cancer careAdvances in radiation oncology:Cancer care
Advances in radiation oncology:Cancer careAjeet Gandhi
 
Nuclear imaging and PET physics
Nuclear imaging and PET physicsNuclear imaging and PET physics
Nuclear imaging and PET physicsLokender Yadav
 

Semelhante a Otto Boerman (20)

What is Nuclear Medicine and PET?
What is Nuclear Medicine and PET?What is Nuclear Medicine and PET?
What is Nuclear Medicine and PET?
 
Preethi
PreethiPreethi
Preethi
 
Precision Oncology: Combining Orthotopic-PDX Models and MRI, Moving Research ...
Precision Oncology: Combining Orthotopic-PDX Models and MRI, Moving Research ...Precision Oncology: Combining Orthotopic-PDX Models and MRI, Moving Research ...
Precision Oncology: Combining Orthotopic-PDX Models and MRI, Moving Research ...
 
Sebastiani Gian Domenico Torino 13° Convegno Patologia Immune E Malattie Orfa...
Sebastiani Gian Domenico Torino 13° Convegno Patologia Immune E Malattie Orfa...Sebastiani Gian Domenico Torino 13° Convegno Patologia Immune E Malattie Orfa...
Sebastiani Gian Domenico Torino 13° Convegno Patologia Immune E Malattie Orfa...
 
A New Frontier of Precision Medicine: Using PET for Image-Guided Neurointerve...
A New Frontier of Precision Medicine: Using PET for Image-Guided Neurointerve...A New Frontier of Precision Medicine: Using PET for Image-Guided Neurointerve...
A New Frontier of Precision Medicine: Using PET for Image-Guided Neurointerve...
 
Interventional Nuclear Medicine Treatment
Interventional Nuclear Medicine TreatmentInterventional Nuclear Medicine Treatment
Interventional Nuclear Medicine Treatment
 
Approaches in clinical trial
Approaches in clinical trialApproaches in clinical trial
Approaches in clinical trial
 
DESTINY – An Innovative Platform for Personalized Medicine from Doctors for D...
DESTINY – An Innovative Platform for Personalized Medicine from Doctors for D...DESTINY – An Innovative Platform for Personalized Medicine from Doctors for D...
DESTINY – An Innovative Platform for Personalized Medicine from Doctors for D...
 
Emerging Role of PRRT.pdf
Emerging Role of PRRT.pdfEmerging Role of PRRT.pdf
Emerging Role of PRRT.pdf
 
Medical Imaging Seminar Company Presentations
Medical Imaging Seminar Company PresentationsMedical Imaging Seminar Company Presentations
Medical Imaging Seminar Company Presentations
 
Certis preclinical slideshare 7.28.18
Certis preclinical slideshare 7.28.18Certis preclinical slideshare 7.28.18
Certis preclinical slideshare 7.28.18
 
MDC Connects Series 2021 | A Guide to Complex Medicines: Physicochemical Char...
MDC Connects Series 2021 | A Guide to Complex Medicines: Physicochemical Char...MDC Connects Series 2021 | A Guide to Complex Medicines: Physicochemical Char...
MDC Connects Series 2021 | A Guide to Complex Medicines: Physicochemical Char...
 
Novio gendix - jack schalken 25032010
Novio gendix - jack schalken 25032010Novio gendix - jack schalken 25032010
Novio gendix - jack schalken 25032010
 
Pet ct in pediatric malignancies
Pet ct in pediatric malignanciesPet ct in pediatric malignancies
Pet ct in pediatric malignancies
 
In Vivo Bioluminescent / Fluorescent Imaging
In Vivo Bioluminescent / Fluorescent ImagingIn Vivo Bioluminescent / Fluorescent Imaging
In Vivo Bioluminescent / Fluorescent Imaging
 
Translational Applications of MiniPDX: An In Vivo Organoid Assay in New Drug R&D
Translational Applications of MiniPDX: An In Vivo Organoid Assay in New Drug R&DTranslational Applications of MiniPDX: An In Vivo Organoid Assay in New Drug R&D
Translational Applications of MiniPDX: An In Vivo Organoid Assay in New Drug R&D
 
Nanotechnology in drug delivery final
Nanotechnology in drug delivery finalNanotechnology in drug delivery final
Nanotechnology in drug delivery final
 
Advances in radiation oncology:Cancer care
Advances in radiation oncology:Cancer careAdvances in radiation oncology:Cancer care
Advances in radiation oncology:Cancer care
 
Theronostics.pptx
Theronostics.pptxTheronostics.pptx
Theronostics.pptx
 
Nuclear imaging and PET physics
Nuclear imaging and PET physicsNuclear imaging and PET physics
Nuclear imaging and PET physics
 

Mais de Health Valley

Keynote Jorrit Ebben (Siza) "HV Afslag Twente" 20-11-2014
Keynote Jorrit Ebben (Siza) "HV Afslag Twente" 20-11-2014 Keynote Jorrit Ebben (Siza) "HV Afslag Twente" 20-11-2014
Keynote Jorrit Ebben (Siza) "HV Afslag Twente" 20-11-2014 Health Valley
 
HV Cafe Road2Germany Minddistrict
HV Cafe Road2Germany MinddistrictHV Cafe Road2Germany Minddistrict
HV Cafe Road2Germany MinddistrictHealth Valley
 
HV Cafe Road2Germany KvK
HV Cafe Road2Germany KvKHV Cafe Road2Germany KvK
HV Cafe Road2Germany KvKHealth Valley
 
HV Cafe Road2Germany
HV Cafe Road2Germany HV Cafe Road2Germany
HV Cafe Road2Germany Health Valley
 
HVE 2014 Pecha Kucha: Pieter van Gorp
HVE 2014 Pecha Kucha: Pieter van GorpHVE 2014 Pecha Kucha: Pieter van Gorp
HVE 2014 Pecha Kucha: Pieter van GorpHealth Valley
 
HVE 2014 Pecha Kucha: Paul de Jonge
HVE 2014 Pecha Kucha: Paul de JongeHVE 2014 Pecha Kucha: Paul de Jonge
HVE 2014 Pecha Kucha: Paul de JongeHealth Valley
 
HVE 2014 Pecha Kucha: Maarten Merckx
HVE 2014 Pecha Kucha: Maarten MerckxHVE 2014 Pecha Kucha: Maarten Merckx
HVE 2014 Pecha Kucha: Maarten MerckxHealth Valley
 
HVE 2014 Pecha Kucha: Jeroen Hasselaar
HVE 2014 Pecha Kucha: Jeroen HasselaarHVE 2014 Pecha Kucha: Jeroen Hasselaar
HVE 2014 Pecha Kucha: Jeroen HasselaarHealth Valley
 
HVE 2014 Pecha Kucha: Charlotte van der Vos
HVE 2014 Pecha Kucha: Charlotte van der VosHVE 2014 Pecha Kucha: Charlotte van der Vos
HVE 2014 Pecha Kucha: Charlotte van der VosHealth Valley
 
HVE 2014 Pecha Kucha: Arieke Janse
HVE 2014 Pecha Kucha: Arieke JanseHVE 2014 Pecha Kucha: Arieke Janse
HVE 2014 Pecha Kucha: Arieke JanseHealth Valley
 
HVE 2014 Pecha Kucha: Stefan Hummelink
HVE 2014 Pecha Kucha: Stefan HummelinkHVE 2014 Pecha Kucha: Stefan Hummelink
HVE 2014 Pecha Kucha: Stefan HummelinkHealth Valley
 
Health Valley Event 2014: Anja Garritsen, Innatoss
Health Valley Event 2014: Anja Garritsen, InnatossHealth Valley Event 2014: Anja Garritsen, Innatoss
Health Valley Event 2014: Anja Garritsen, InnatossHealth Valley
 
Health Valley Event 2014: Jan Raaijmakers, Universiteit Utrecht
Health Valley Event 2014: Jan Raaijmakers, Universiteit UtrechtHealth Valley Event 2014: Jan Raaijmakers, Universiteit Utrecht
Health Valley Event 2014: Jan Raaijmakers, Universiteit UtrechtHealth Valley
 
Health Valley Event 2014: Alain van Gool, Radboudumc
Health Valley Event 2014: Alain van Gool, RadboudumcHealth Valley Event 2014: Alain van Gool, Radboudumc
Health Valley Event 2014: Alain van Gool, RadboudumcHealth Valley
 
Health Valley Event 2014: Han van Krieken, Radboudumc
Health Valley Event 2014: Han van Krieken, RadboudumcHealth Valley Event 2014: Han van Krieken, Radboudumc
Health Valley Event 2014: Han van Krieken, RadboudumcHealth Valley
 
Health Valley Event 2014: Chiel Bos, CPZ
Health Valley Event 2014: Chiel Bos, CPZHealth Valley Event 2014: Chiel Bos, CPZ
Health Valley Event 2014: Chiel Bos, CPZHealth Valley
 
Health Valley 2014: Dick Herfst
Health Valley 2014: Dick HerfstHealth Valley 2014: Dick Herfst
Health Valley 2014: Dick HerfstHealth Valley
 
Health Valley 2014: Jack Schalken
Health Valley 2014: Jack SchalkenHealth Valley 2014: Jack Schalken
Health Valley 2014: Jack SchalkenHealth Valley
 
Health Valley Event 2014: Co Politiek, Aimpact
Health Valley Event 2014: Co Politiek, Aimpact Health Valley Event 2014: Co Politiek, Aimpact
Health Valley Event 2014: Co Politiek, Aimpact Health Valley
 
Health Valley Event 2014: Marieke Hettinga, Windesheim
Health Valley Event 2014: Marieke Hettinga, WindesheimHealth Valley Event 2014: Marieke Hettinga, Windesheim
Health Valley Event 2014: Marieke Hettinga, WindesheimHealth Valley
 

Mais de Health Valley (20)

Keynote Jorrit Ebben (Siza) "HV Afslag Twente" 20-11-2014
Keynote Jorrit Ebben (Siza) "HV Afslag Twente" 20-11-2014 Keynote Jorrit Ebben (Siza) "HV Afslag Twente" 20-11-2014
Keynote Jorrit Ebben (Siza) "HV Afslag Twente" 20-11-2014
 
HV Cafe Road2Germany Minddistrict
HV Cafe Road2Germany MinddistrictHV Cafe Road2Germany Minddistrict
HV Cafe Road2Germany Minddistrict
 
HV Cafe Road2Germany KvK
HV Cafe Road2Germany KvKHV Cafe Road2Germany KvK
HV Cafe Road2Germany KvK
 
HV Cafe Road2Germany
HV Cafe Road2Germany HV Cafe Road2Germany
HV Cafe Road2Germany
 
HVE 2014 Pecha Kucha: Pieter van Gorp
HVE 2014 Pecha Kucha: Pieter van GorpHVE 2014 Pecha Kucha: Pieter van Gorp
HVE 2014 Pecha Kucha: Pieter van Gorp
 
HVE 2014 Pecha Kucha: Paul de Jonge
HVE 2014 Pecha Kucha: Paul de JongeHVE 2014 Pecha Kucha: Paul de Jonge
HVE 2014 Pecha Kucha: Paul de Jonge
 
HVE 2014 Pecha Kucha: Maarten Merckx
HVE 2014 Pecha Kucha: Maarten MerckxHVE 2014 Pecha Kucha: Maarten Merckx
HVE 2014 Pecha Kucha: Maarten Merckx
 
HVE 2014 Pecha Kucha: Jeroen Hasselaar
HVE 2014 Pecha Kucha: Jeroen HasselaarHVE 2014 Pecha Kucha: Jeroen Hasselaar
HVE 2014 Pecha Kucha: Jeroen Hasselaar
 
HVE 2014 Pecha Kucha: Charlotte van der Vos
HVE 2014 Pecha Kucha: Charlotte van der VosHVE 2014 Pecha Kucha: Charlotte van der Vos
HVE 2014 Pecha Kucha: Charlotte van der Vos
 
HVE 2014 Pecha Kucha: Arieke Janse
HVE 2014 Pecha Kucha: Arieke JanseHVE 2014 Pecha Kucha: Arieke Janse
HVE 2014 Pecha Kucha: Arieke Janse
 
HVE 2014 Pecha Kucha: Stefan Hummelink
HVE 2014 Pecha Kucha: Stefan HummelinkHVE 2014 Pecha Kucha: Stefan Hummelink
HVE 2014 Pecha Kucha: Stefan Hummelink
 
Health Valley Event 2014: Anja Garritsen, Innatoss
Health Valley Event 2014: Anja Garritsen, InnatossHealth Valley Event 2014: Anja Garritsen, Innatoss
Health Valley Event 2014: Anja Garritsen, Innatoss
 
Health Valley Event 2014: Jan Raaijmakers, Universiteit Utrecht
Health Valley Event 2014: Jan Raaijmakers, Universiteit UtrechtHealth Valley Event 2014: Jan Raaijmakers, Universiteit Utrecht
Health Valley Event 2014: Jan Raaijmakers, Universiteit Utrecht
 
Health Valley Event 2014: Alain van Gool, Radboudumc
Health Valley Event 2014: Alain van Gool, RadboudumcHealth Valley Event 2014: Alain van Gool, Radboudumc
Health Valley Event 2014: Alain van Gool, Radboudumc
 
Health Valley Event 2014: Han van Krieken, Radboudumc
Health Valley Event 2014: Han van Krieken, RadboudumcHealth Valley Event 2014: Han van Krieken, Radboudumc
Health Valley Event 2014: Han van Krieken, Radboudumc
 
Health Valley Event 2014: Chiel Bos, CPZ
Health Valley Event 2014: Chiel Bos, CPZHealth Valley Event 2014: Chiel Bos, CPZ
Health Valley Event 2014: Chiel Bos, CPZ
 
Health Valley 2014: Dick Herfst
Health Valley 2014: Dick HerfstHealth Valley 2014: Dick Herfst
Health Valley 2014: Dick Herfst
 
Health Valley 2014: Jack Schalken
Health Valley 2014: Jack SchalkenHealth Valley 2014: Jack Schalken
Health Valley 2014: Jack Schalken
 
Health Valley Event 2014: Co Politiek, Aimpact
Health Valley Event 2014: Co Politiek, Aimpact Health Valley Event 2014: Co Politiek, Aimpact
Health Valley Event 2014: Co Politiek, Aimpact
 
Health Valley Event 2014: Marieke Hettinga, Windesheim
Health Valley Event 2014: Marieke Hettinga, WindesheimHealth Valley Event 2014: Marieke Hettinga, Windesheim
Health Valley Event 2014: Marieke Hettinga, Windesheim
 

Otto Boerman

Notas do Editor

  1. At the moment more than 180 million people worldwide suffer from diabetes and an increase of the incidence of diabetes is expected.
  2. MIP maximum intensity projection VRT volume rendering technique